SOADOR
RGNX icon

State of Alaska Department of Revenue’s Regenxbio RGNX Stock Holding History

State of Alaska Department of Revenue’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31K Hold
2,597
– – ﹤0.01% 2012
2026
Q1 		$21K Hold
2,597
– – ﹤0.01% 2075
2025
Q4 		$37K Hold
2,597
– – ﹤0.01% 1974
2025
Q3 		$25K Buy
+2,597
New +$23K ﹤0.01% 1952
2024
Q4 		– Sell
-25,948
Closed -$272K – 1605
2024
Q3 		$272K Sell
25,948
-657
-2% -$8.01K ﹤0.01% 1555
2024
Q2 		$311K Buy
26,605
+1,949
+8% +$30.3K ﹤0.01% 1523
2024
Q1 		$519K Sell
24,656
-243
-1% -$4.32K 0.01% 1359
2023
Q4 		$446K Sell
24,899
-281
-1% -$4.95K 0.01% 1423
2023
Q3 		$414K Buy
25,180
+298
+1% +$5.4K 0.01% 1412
2023
Q2 		$497K Sell
24,882
-911
-4% -$17.6K 0.01% 1365
2023
Q1 		$487K Sell
25,793
-434
-2% -$9.6K 0.01% 1376
2022
Q4 		$594K Buy
26,227
+188
+0.7% +$4.25K 0.01% 1264
2022
Q3 		$688K Sell
26,039
-2,558
-9% -$75.9K 0.01% 1125
2022
Q2 		$706K Buy
28,597
+2,420
+9% +$60.5K 0.01% 1166
2022
Q1 		$868K Sell
26,177
-475
-2% -$13.2K 0.01% 1103
2021
Q4 		$871K Sell
26,652
-695
-3% -$23.7K 0.01% 1166
2021
Q3 		$1.15M Buy
27,347
+3,226
+13% +$116K 0.01% 1011
2021
Q2 		$937K Buy
24,121
+525
+2% +$18.8K 0.01% 1131
2021
Q1 		$804K Buy
23,596
+310
+1% +$13.2K 0.01% 1182
2020
Q4 		$1.06M Sell
23,286
-4,528
-16% -$158K 0.01% 934
2020
Q3 		$765K Sell
27,814
-2,040
-7% -$66.5K 0.01% 1016
2020
Q2 		$1.1M Buy
29,854
+880
+3% +$32.8K 0.01% 817
2020
Q1 		$938K Buy
28,974
+5,310
+22% +$221K 0.01% 795
2019
Q4 		$969K Sell
23,664
-374
-2% -$14.8K 0.01% 920
2019
Q3 		$855K Buy
24,038
+13,564
+130% +$550K 0.01% 959
2019
Q2 		$538K Buy
10,474
+164
+2% +$8.19K 0.01% 1025
2019
Q1 		$590K Buy
10,310
+245
+2% +$12.1K 0.01% 959
2018
Q4 		$422K Buy
10,065
+475
+5% +$27.9K 0.01% 1065
2018
Q3 		$724K Buy
9,590
+820
+9% +$59.1K 0.01% 884
2018
Q2 		$629K Buy
+8,770
New +$419K 0.01% 929

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $78.6B AUM 28.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

State of Alaska Department of Revenue's RGNX Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Regenxbio (RGNX) position steady in Q2 2026 at 2,597 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

State of Alaska Department of Revenue first reported a position in RGNX in Q2 2018 and has held it in 30 quarters since. The position peaked at $1.15M in Q3 2021. 80 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • State of Alaska Department of Revenue held 2,597 shares of Regenxbio worth $31K as of Q2 2026.
  • State of Alaska Department of Revenue left its Regenxbio share count unchanged in Q2 2026.
  • Regenxbio made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #2012 holding.
  • State of Alaska Department of Revenue first reported a position in Regenxbio in Q2 2018 and has held it in 30 quarters since.
  • State of Alaska Department of Revenue's Regenxbio position peaked at $1.15M in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.